Mark Nehler
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 32 | 2024 | 456 | 4.320 |
Why?
| Ischemia | 30 | 2024 | 394 | 4.180 |
Why?
| Internship and Residency | 17 | 2024 | 1043 | 2.460 |
Why?
| Lower Extremity | 21 | 2024 | 401 | 2.440 |
Why?
| Vascular Surgical Procedures | 25 | 2024 | 294 | 2.210 |
Why?
| General Surgery | 10 | 2024 | 152 | 2.050 |
Why?
| Rivaroxaban | 19 | 2024 | 252 | 1.980 |
Why?
| Endovascular Procedures | 11 | 2024 | 302 | 1.640 |
Why?
| Leg | 14 | 2007 | 236 | 1.490 |
Why?
| Platelet Aggregation Inhibitors | 17 | 2024 | 439 | 1.470 |
Why?
| Peripheral Vascular Diseases | 12 | 2022 | 102 | 1.350 |
Why?
| Aspirin | 16 | 2024 | 377 | 1.270 |
Why?
| Factor Xa Inhibitors | 9 | 2024 | 169 | 1.020 |
Why?
| Blood Vessel Prosthesis Implantation | 6 | 2023 | 198 | 1.020 |
Why?
| Limb Salvage | 10 | 2024 | 57 | 1.020 |
Why?
| Surgeons | 4 | 2021 | 259 | 0.900 |
Why?
| Femoral Artery | 10 | 2023 | 170 | 0.840 |
Why?
| Education, Medical, Graduate | 6 | 2024 | 433 | 0.820 |
Why?
| Arterial Occlusive Diseases | 7 | 2008 | 79 | 0.810 |
Why?
| Treatment Outcome | 46 | 2024 | 10110 | 0.790 |
Why?
| Risk Factors | 36 | 2025 | 9696 | 0.710 |
Why?
| Aortic Aneurysm, Abdominal | 3 | 2017 | 132 | 0.710 |
Why?
| Career Choice | 4 | 2024 | 207 | 0.690 |
Why?
| Popliteal Artery | 7 | 2023 | 58 | 0.680 |
Why?
| Puerperal Disorders | 1 | 2020 | 30 | 0.670 |
Why?
| Intermittent Claudication | 12 | 2022 | 118 | 0.670 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 77 | 0.660 |
Why?
| Venous Thromboembolism | 4 | 2025 | 271 | 0.650 |
Why?
| Personnel Selection | 3 | 2018 | 72 | 0.640 |
Why?
| Postoperative Complications | 12 | 2024 | 2456 | 0.630 |
Why?
| Thrombosis | 5 | 2024 | 323 | 0.630 |
Why?
| Vascular System Injuries | 4 | 2021 | 72 | 0.600 |
Why?
| Aged | 50 | 2025 | 21892 | 0.600 |
Why?
| Vascular Patency | 13 | 2023 | 102 | 0.590 |
Why?
| Humans | 116 | 2025 | 128019 | 0.580 |
Why?
| Time Factors | 21 | 2022 | 6479 | 0.570 |
Why?
| Risk Assessment | 16 | 2025 | 3223 | 0.560 |
Why?
| Male | 74 | 2025 | 62757 | 0.560 |
Why?
| Coronary Artery Disease | 5 | 2024 | 675 | 0.540 |
Why?
| Female | 69 | 2025 | 68016 | 0.530 |
Why?
| Quality Indicators, Health Care | 3 | 2016 | 296 | 0.510 |
Why?
| Clinical Competence | 4 | 2022 | 1007 | 0.510 |
Why?
| Elective Surgical Procedures | 2 | 2017 | 162 | 0.500 |
Why?
| Middle Aged | 51 | 2025 | 30812 | 0.500 |
Why?
| Mentors | 2 | 2020 | 178 | 0.490 |
Why?
| Arteriovenous Shunt, Surgical | 2 | 2011 | 16 | 0.440 |
Why?
| Angioplasty, Balloon | 3 | 2023 | 88 | 0.420 |
Why?
| Renal Dialysis | 3 | 2013 | 420 | 0.410 |
Why?
| Upper Extremity | 2 | 2011 | 92 | 0.410 |
Why?
| Retrospective Studies | 27 | 2024 | 14404 | 0.410 |
Why?
| Aged, 80 and over | 22 | 2024 | 7029 | 0.410 |
Why?
| Incidence | 10 | 2025 | 2614 | 0.400 |
Why?
| Paclitaxel | 3 | 2021 | 213 | 0.390 |
Why?
| Kidney Failure, Chronic | 4 | 2013 | 540 | 0.360 |
Why?
| Patient Care Management | 1 | 2011 | 56 | 0.350 |
Why?
| Drug Therapy, Combination | 9 | 2024 | 1012 | 0.340 |
Why?
| Alprostadil | 2 | 2007 | 32 | 0.340 |
Why?
| Activities of Daily Living | 4 | 2006 | 381 | 0.330 |
Why?
| Medicaid | 1 | 2014 | 433 | 0.330 |
Why?
| Quality of Life | 6 | 2022 | 2672 | 0.330 |
Why?
| Patient Readmission | 5 | 2023 | 663 | 0.320 |
Why?
| Wound Healing | 5 | 2009 | 298 | 0.320 |
Why?
| Adult | 33 | 2025 | 35176 | 0.310 |
Why?
| Medicare | 1 | 2014 | 715 | 0.310 |
Why?
| Continuity of Patient Care | 1 | 2011 | 275 | 0.300 |
Why?
| Brain Ischemia | 2 | 2022 | 305 | 0.300 |
Why?
| Drug-Eluting Stents | 2 | 2021 | 64 | 0.300 |
Why?
| United States | 17 | 2025 | 13785 | 0.300 |
Why?
| Kidney Diseases | 2 | 2011 | 370 | 0.290 |
Why?
| Comorbidity | 7 | 2017 | 1537 | 0.280 |
Why?
| Students, Medical | 2 | 2023 | 315 | 0.280 |
Why?
| Decision Support Techniques | 2 | 2021 | 396 | 0.270 |
Why?
| Stroke | 3 | 2022 | 1063 | 0.270 |
Why?
| Ribs | 2 | 2016 | 33 | 0.270 |
Why?
| Critical Illness | 6 | 2020 | 755 | 0.270 |
Why?
| Curriculum | 5 | 2024 | 909 | 0.270 |
Why?
| Surveys and Questionnaires | 10 | 2024 | 5353 | 0.270 |
Why?
| Computer Simulation | 1 | 2011 | 936 | 0.270 |
Why?
| Prodrugs | 1 | 2007 | 48 | 0.270 |
Why?
| Anticoagulants | 5 | 2025 | 615 | 0.260 |
Why?
| Neoplasms | 1 | 2021 | 2460 | 0.260 |
Why?
| Myocardial Infarction | 3 | 2022 | 1013 | 0.260 |
Why?
| Software | 1 | 2011 | 606 | 0.260 |
Why?
| Venous Thrombosis | 2 | 2025 | 161 | 0.260 |
Why?
| Thoracic Outlet Syndrome | 2 | 2016 | 15 | 0.250 |
Why?
| Hemorrhage | 7 | 2023 | 643 | 0.250 |
Why?
| Atherosclerosis | 2 | 2020 | 403 | 0.240 |
Why?
| Attitude of Health Personnel | 3 | 2024 | 1088 | 0.240 |
Why?
| Catheterization, Peripheral | 2 | 2009 | 104 | 0.240 |
Why?
| Reoperation | 10 | 2014 | 541 | 0.240 |
Why?
| Femoral Vein | 3 | 2008 | 32 | 0.230 |
Why?
| Cardiovascular Surgical Procedures | 2 | 2001 | 28 | 0.230 |
Why?
| Graft Occlusion, Vascular | 3 | 2011 | 39 | 0.230 |
Why?
| Iliac Aneurysm | 2 | 2022 | 19 | 0.230 |
Why?
| Carotid Stenosis | 2 | 1996 | 85 | 0.230 |
Why?
| Parental Leave | 1 | 2024 | 23 | 0.220 |
Why?
| Patient Care Team | 2 | 2024 | 597 | 0.220 |
Why?
| Fibrinolytic Agents | 3 | 2022 | 248 | 0.220 |
Why?
| Urology | 1 | 2024 | 57 | 0.220 |
Why?
| Ultrasonography, Doppler | 2 | 2021 | 118 | 0.220 |
Why?
| Chi-Square Distribution | 3 | 2017 | 511 | 0.210 |
Why?
| Acute Disease | 4 | 2021 | 961 | 0.210 |
Why?
| Cranial Nerve Injuries | 1 | 2023 | 5 | 0.210 |
Why?
| Diabetes Complications | 3 | 2015 | 223 | 0.210 |
Why?
| Carotid Body Tumor | 1 | 2023 | 5 | 0.210 |
Why?
| Double-Blind Method | 8 | 2024 | 1852 | 0.210 |
Why?
| Academic Medical Centers | 3 | 2017 | 478 | 0.200 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 78 | 0.200 |
Why?
| Antifibrinolytic Agents | 1 | 2023 | 47 | 0.200 |
Why?
| Pulmonary Embolism | 1 | 2025 | 202 | 0.200 |
Why?
| Diabetic Foot | 2 | 2019 | 24 | 0.200 |
Why?
| Tibial Arteries | 4 | 2008 | 12 | 0.200 |
Why?
| Cholesterol, LDL | 1 | 2024 | 357 | 0.190 |
Why?
| Meditation | 1 | 2022 | 38 | 0.190 |
Why?
| Thrombolytic Therapy | 1 | 2003 | 131 | 0.190 |
Why?
| Blood Coagulation Disorders | 1 | 2023 | 162 | 0.180 |
Why?
| Blood Vessel Prosthesis | 3 | 2022 | 124 | 0.180 |
Why?
| Smoking Cessation | 2 | 2002 | 407 | 0.180 |
Why?
| Faculty, Medical | 1 | 2024 | 263 | 0.180 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2023 | 127 | 0.180 |
Why?
| Quality Improvement | 2 | 2022 | 1093 | 0.180 |
Why?
| Heparin | 3 | 2023 | 246 | 0.180 |
Why?
| Outpatients | 1 | 2024 | 366 | 0.180 |
Why?
| Hemostatic Techniques | 1 | 2001 | 45 | 0.180 |
Why?
| Specialties, Surgical | 2 | 2017 | 73 | 0.170 |
Why?
| Suture Techniques | 1 | 2001 | 117 | 0.170 |
Why?
| Hospital Departments | 1 | 2020 | 9 | 0.170 |
Why?
| Aortic Diseases | 1 | 2001 | 114 | 0.170 |
Why?
| Hyperlipidemias | 1 | 2001 | 125 | 0.170 |
Why?
| Blood Pressure Determination | 1 | 2021 | 148 | 0.170 |
Why?
| Mentoring | 1 | 2022 | 130 | 0.170 |
Why?
| Forefoot, Human | 1 | 1999 | 1 | 0.170 |
Why?
| Multivariate Analysis | 4 | 2019 | 1492 | 0.160 |
Why?
| Toes | 1 | 1999 | 15 | 0.160 |
Why?
| Logistic Models | 3 | 2017 | 1975 | 0.160 |
Why?
| Aneurysm | 2 | 1997 | 29 | 0.160 |
Why?
| Proportional Hazards Models | 3 | 2021 | 1194 | 0.160 |
Why?
| Databases, Factual | 4 | 2017 | 1264 | 0.160 |
Why?
| Canagliflozin | 1 | 2019 | 9 | 0.160 |
Why?
| Patient Selection | 4 | 2014 | 658 | 0.160 |
Why?
| Self Concept | 1 | 2021 | 241 | 0.160 |
Why?
| Walking | 4 | 2022 | 494 | 0.160 |
Why?
| Counseling | 1 | 2002 | 382 | 0.160 |
Why?
| Clinical Clerkship | 1 | 2020 | 95 | 0.160 |
Why?
| Chronic Disease | 6 | 2011 | 1690 | 0.150 |
Why?
| Carotid Artery Diseases | 1 | 2019 | 64 | 0.150 |
Why?
| Drug Prescriptions | 1 | 2020 | 245 | 0.150 |
Why?
| Iatrogenic Disease | 1 | 1998 | 54 | 0.150 |
Why?
| School Admission Criteria | 1 | 2018 | 23 | 0.150 |
Why?
| Exercise Therapy | 2 | 2001 | 412 | 0.150 |
Why?
| Cardiovascular Diseases | 5 | 2024 | 1994 | 0.150 |
Why?
| Extremities | 2 | 2009 | 128 | 0.150 |
Why?
| Blood Vessels | 2 | 1998 | 181 | 0.150 |
Why?
| Follow-Up Studies | 9 | 2021 | 4853 | 0.140 |
Why?
| Odds Ratio | 3 | 2016 | 1018 | 0.140 |
Why?
| Arm | 2 | 2004 | 106 | 0.140 |
Why?
| Arteriosclerosis | 1 | 1997 | 88 | 0.140 |
Why?
| Cost of Illness | 1 | 2019 | 277 | 0.140 |
Why?
| Physician Executives | 1 | 2017 | 33 | 0.140 |
Why?
| Hospitalization | 2 | 2025 | 2057 | 0.140 |
Why?
| Ultrasonography, Doppler, Duplex | 2 | 1996 | 43 | 0.140 |
Why?
| Diabetes Mellitus | 3 | 2021 | 994 | 0.140 |
Why?
| Homocysteine | 1 | 1997 | 149 | 0.140 |
Why?
| Subclavian Artery | 1 | 1997 | 28 | 0.140 |
Why?
| Vascular Diseases | 2 | 2015 | 232 | 0.140 |
Why?
| Tertiary Care Centers | 1 | 2017 | 146 | 0.130 |
Why?
| Incidental Findings | 1 | 2016 | 79 | 0.130 |
Why?
| Burnout, Professional | 1 | 2022 | 407 | 0.130 |
Why?
| Endarterectomy, Carotid | 2 | 2013 | 47 | 0.130 |
Why?
| Vascular Malformations | 1 | 2016 | 50 | 0.130 |
Why?
| Osteotomy | 1 | 2016 | 99 | 0.130 |
Why?
| Sepsis | 2 | 2016 | 562 | 0.130 |
Why?
| Survival Rate | 4 | 2021 | 1870 | 0.120 |
Why?
| Interprofessional Relations | 1 | 2017 | 270 | 0.120 |
Why?
| Kaplan-Meier Estimate | 4 | 2021 | 851 | 0.120 |
Why?
| Popliteal Vein | 1 | 1994 | 4 | 0.120 |
Why?
| Multidetector Computed Tomography | 1 | 2014 | 32 | 0.110 |
Why?
| Hypertension | 2 | 2001 | 1234 | 0.110 |
Why?
| Disease Progression | 3 | 2014 | 2598 | 0.110 |
Why?
| Endarterectomy | 1 | 1993 | 6 | 0.110 |
Why?
| Multiple Trauma | 1 | 2014 | 101 | 0.110 |
Why?
| Thoracotomy | 1 | 2014 | 74 | 0.110 |
Why?
| Premedication | 1 | 1993 | 41 | 0.110 |
Why?
| Bandages | 1 | 1993 | 32 | 0.110 |
Why?
| Surgery, Computer-Assisted | 1 | 2014 | 76 | 0.110 |
Why?
| Recurrence | 4 | 2014 | 993 | 0.110 |
Why?
| Recovery of Function | 3 | 2011 | 630 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 872 | 0.100 |
Why?
| Analgesics, Opioid | 1 | 2020 | 886 | 0.100 |
Why?
| Ischemic Attack, Transient | 1 | 1993 | 60 | 0.100 |
Why?
| Ulnar Artery | 1 | 1992 | 2 | 0.100 |
Why?
| Injury Severity Score | 3 | 2021 | 509 | 0.100 |
Why?
| Research Design | 2 | 2009 | 1034 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 1272 | 0.100 |
Why?
| Life Tables | 3 | 1998 | 18 | 0.100 |
Why?
| Stress, Psychological | 1 | 2020 | 1060 | 0.100 |
Why?
| Predictive Value of Tests | 4 | 2021 | 1934 | 0.100 |
Why?
| Renal Insufficiency | 1 | 2014 | 148 | 0.100 |
Why?
| Radial Artery | 1 | 1992 | 69 | 0.100 |
Why?
| Fingers | 1 | 1992 | 86 | 0.100 |
Why?
| Research Personnel | 1 | 2013 | 156 | 0.100 |
Why?
| Seasons | 1 | 2014 | 498 | 0.100 |
Why?
| Angiography | 2 | 2024 | 192 | 0.100 |
Why?
| Pregnancy | 2 | 2024 | 6355 | 0.090 |
Why?
| Thrombectomy | 2 | 2003 | 59 | 0.090 |
Why?
| Prognosis | 5 | 2021 | 3766 | 0.090 |
Why?
| Aorta, Thoracic | 1 | 2014 | 260 | 0.090 |
Why?
| Oregon | 1 | 2011 | 69 | 0.090 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2024 | 1356 | 0.090 |
Why?
| Young Adult | 6 | 2021 | 12281 | 0.090 |
Why?
| Efficiency | 1 | 2011 | 91 | 0.090 |
Why?
| Fellowships and Scholarships | 1 | 2013 | 271 | 0.090 |
Why?
| Hypoglycemic Agents | 1 | 2019 | 1212 | 0.080 |
Why?
| Reproducibility of Results | 3 | 2021 | 3009 | 0.080 |
Why?
| Arteries | 2 | 2022 | 261 | 0.080 |
Why?
| Catheterization | 2 | 2003 | 171 | 0.080 |
Why?
| Adolescent | 7 | 2023 | 20158 | 0.080 |
Why?
| Registries | 3 | 2025 | 1873 | 0.080 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2009 | 27 | 0.080 |
Why?
| Device Approval | 1 | 2009 | 21 | 0.080 |
Why?
| Workload | 1 | 2011 | 150 | 0.080 |
Why?
| Disability Evaluation | 1 | 2011 | 285 | 0.080 |
Why?
| Coated Materials, Biocompatible | 2 | 2023 | 56 | 0.080 |
Why?
| Safety | 1 | 2011 | 328 | 0.080 |
Why?
| Risk Management | 3 | 2007 | 85 | 0.080 |
Why?
| Axillary Vein | 1 | 2008 | 4 | 0.080 |
Why?
| Skin | 1 | 1993 | 711 | 0.080 |
Why?
| Global Health | 2 | 2021 | 327 | 0.080 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2024 | 410 | 0.070 |
Why?
| Saphenous Vein | 3 | 1998 | 32 | 0.070 |
Why?
| Radiography | 4 | 2015 | 794 | 0.070 |
Why?
| Athletic Injuries | 1 | 2014 | 506 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1943 | 0.070 |
Why?
| Colorado | 3 | 2016 | 4369 | 0.070 |
Why?
| Practice Guidelines as Topic | 2 | 2011 | 1482 | 0.070 |
Why?
| Biomedical Research | 1 | 2013 | 632 | 0.070 |
Why?
| Prevalence | 1 | 2014 | 2541 | 0.070 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2021 | 185 | 0.070 |
Why?
| Family Practice | 2 | 2020 | 434 | 0.070 |
Why?
| Brachial Artery | 1 | 2008 | 185 | 0.070 |
Why?
| Iloprost | 1 | 2006 | 45 | 0.060 |
Why?
| Prospective Studies | 5 | 2021 | 7035 | 0.060 |
Why?
| Chemotherapy, Adjuvant | 1 | 2007 | 377 | 0.060 |
Why?
| Exercise Test | 3 | 2011 | 613 | 0.060 |
Why?
| Carotid Artery, Internal | 2 | 1996 | 41 | 0.060 |
Why?
| Regional Blood Flow | 2 | 1999 | 457 | 0.060 |
Why?
| United States Department of Veterans Affairs | 1 | 2009 | 633 | 0.060 |
Why?
| Sulfonic Acids | 1 | 2004 | 13 | 0.060 |
Why?
| Thrombophilia | 1 | 2025 | 66 | 0.060 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2428 | 0.060 |
Why?
| Single-Blind Method | 2 | 2015 | 267 | 0.060 |
Why?
| Acetates | 1 | 2004 | 96 | 0.060 |
Why?
| Veins | 2 | 1995 | 58 | 0.050 |
Why?
| Specialty Boards | 1 | 2024 | 32 | 0.050 |
Why?
| Clinical Trials as Topic | 1 | 2008 | 997 | 0.050 |
Why?
| Thromboplastin | 1 | 2023 | 69 | 0.050 |
Why?
| Blood Pressure | 2 | 2021 | 1711 | 0.050 |
Why?
| Atherectomy | 1 | 2023 | 36 | 0.050 |
Why?
| Survival Analysis | 2 | 2004 | 1262 | 0.050 |
Why?
| Physical Exertion | 1 | 2004 | 207 | 0.050 |
Why?
| Forecasting | 2 | 2001 | 355 | 0.050 |
Why?
| Preoperative Care | 2 | 2002 | 335 | 0.050 |
Why?
| Sexism | 1 | 2023 | 55 | 0.050 |
Why?
| Diagnostic Techniques, Cardiovascular | 1 | 2002 | 11 | 0.050 |
Why?
| Societies, Medical | 2 | 2009 | 741 | 0.050 |
Why?
| Numbers Needed To Treat | 1 | 2021 | 7 | 0.050 |
Why?
| Morbidity | 1 | 2023 | 301 | 0.050 |
Why?
| Mobility Limitation | 1 | 2022 | 58 | 0.050 |
Why?
| Off-Label Use | 1 | 2022 | 51 | 0.050 |
Why?
| Psychomotor Performance | 1 | 2004 | 311 | 0.050 |
Why?
| Mass Screening | 1 | 2009 | 1145 | 0.050 |
Why?
| Frailty | 1 | 2024 | 153 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2025 | 518 | 0.050 |
Why?
| Educational Measurement | 1 | 2024 | 257 | 0.050 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2001 | 6 | 0.050 |
Why?
| Vascular Neoplasms | 1 | 2001 | 17 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 809 | 0.050 |
Why?
| Angioplasty | 1 | 2001 | 47 | 0.040 |
Why?
| Cadaver | 1 | 2022 | 306 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2004 | 669 | 0.040 |
Why?
| Tetrazoles | 1 | 2001 | 37 | 0.040 |
Why?
| Heart Failure | 1 | 2014 | 2141 | 0.040 |
Why?
| Aneurysm, False | 1 | 2001 | 48 | 0.040 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 219 | 0.040 |
Why?
| Habits | 1 | 2020 | 43 | 0.040 |
Why?
| Equipment Failure | 1 | 2001 | 107 | 0.040 |
Why?
| Joint Dislocations | 1 | 2021 | 50 | 0.040 |
Why?
| Physician's Role | 1 | 2002 | 203 | 0.040 |
Why?
| Arterial Pressure | 1 | 2021 | 116 | 0.040 |
Why?
| Radiography, Interventional | 1 | 2001 | 104 | 0.040 |
Why?
| Stents | 2 | 2022 | 504 | 0.040 |
Why?
| Severity of Illness Index | 2 | 2008 | 2703 | 0.040 |
Why?
| Empathy | 1 | 2022 | 170 | 0.040 |
Why?
| Prosthesis Design | 1 | 2022 | 302 | 0.040 |
Why?
| Artificial Limbs | 1 | 2003 | 170 | 0.040 |
Why?
| Diagnostic Imaging | 3 | 2007 | 329 | 0.040 |
Why?
| Pregnancy Complications, Infectious | 1 | 2024 | 363 | 0.040 |
Why?
| Internationality | 1 | 2020 | 149 | 0.040 |
Why?
| Internal Medicine | 1 | 2002 | 246 | 0.040 |
Why?
| Toe Joint | 1 | 1999 | 4 | 0.040 |
Why?
| Pulse | 1 | 1999 | 25 | 0.040 |
Why?
| Knee Injuries | 1 | 2021 | 99 | 0.040 |
Why?
| Proprotein Convertase 9 | 1 | 2020 | 68 | 0.040 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 198 | 0.040 |
Why?
| Pulsatile Flow | 1 | 1999 | 59 | 0.040 |
Why?
| Metatarsal Bones | 1 | 1999 | 21 | 0.040 |
Why?
| Patient Education as Topic | 1 | 2024 | 733 | 0.040 |
Why?
| Debridement | 1 | 1999 | 82 | 0.040 |
Why?
| Myocardial Revascularization | 1 | 2019 | 70 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2020 | 222 | 0.040 |
Why?
| Arteriovenous Fistula | 1 | 1998 | 35 | 0.040 |
Why?
| Catheters, Indwelling | 1 | 1998 | 76 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 235 | 0.040 |
Why?
| Intraoperative Complications | 1 | 1998 | 129 | 0.040 |
Why?
| Knee Joint | 1 | 2021 | 366 | 0.040 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2018 | 66 | 0.030 |
Why?
| Carotid Arteries | 1 | 2019 | 194 | 0.030 |
Why?
| Antiviral Agents | 1 | 2023 | 710 | 0.030 |
Why?
| Coronary Disease | 1 | 2000 | 384 | 0.030 |
Why?
| Diagnosis, Differential | 2 | 2014 | 1408 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2020 | 1199 | 0.030 |
Why?
| Age Factors | 1 | 2004 | 3100 | 0.030 |
Why?
| Neck | 1 | 1997 | 92 | 0.030 |
Why?
| Administration, Oral | 1 | 2019 | 766 | 0.030 |
Why?
| Health Promotion | 1 | 2022 | 716 | 0.030 |
Why?
| Blood Loss, Surgical | 1 | 2016 | 90 | 0.030 |
Why?
| Risk | 1 | 2019 | 850 | 0.030 |
Why?
| Cardiology | 1 | 2019 | 260 | 0.030 |
Why?
| Postoperative Hemorrhage | 1 | 2016 | 86 | 0.030 |
Why?
| Fractures, Bone | 1 | 2021 | 393 | 0.030 |
Why?
| Foot | 1 | 1996 | 92 | 0.030 |
Why?
| Pain Measurement | 2 | 2009 | 478 | 0.030 |
Why?
| Aortic Rupture | 1 | 1995 | 25 | 0.030 |
Why?
| Aorta, Abdominal | 1 | 1995 | 42 | 0.030 |
Why?
| Groin | 1 | 1994 | 10 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1343 | 0.030 |
Why?
| Carotid Artery, External | 1 | 1993 | 3 | 0.030 |
Why?
| Glasgow Coma Scale | 1 | 2014 | 167 | 0.030 |
Why?
| Orthopedic Equipment | 1 | 1993 | 5 | 0.030 |
Why?
| Venous Insufficiency | 1 | 1993 | 12 | 0.030 |
Why?
| Prosthesis Failure | 1 | 1994 | 112 | 0.030 |
Why?
| Operative Time | 1 | 2014 | 121 | 0.030 |
Why?
| Cerebral Revascularization | 1 | 1993 | 19 | 0.030 |
Why?
| Tomography, X-Ray Computed | 2 | 2016 | 2509 | 0.030 |
Why?
| Carotid Artery, Common | 1 | 1993 | 35 | 0.030 |
Why?
| Cerebral Angiography | 1 | 1993 | 109 | 0.030 |
Why?
| Ankle | 1 | 1993 | 61 | 0.030 |
Why?
| Exercise | 1 | 2004 | 1917 | 0.030 |
Why?
| Arteritis | 1 | 1993 | 24 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2016 | 281 | 0.030 |
Why?
| Longitudinal Studies | 2 | 1999 | 2706 | 0.030 |
Why?
| Pressure | 1 | 1993 | 236 | 0.030 |
Why?
| Housing | 1 | 1993 | 130 | 0.020 |
Why?
| Inflammation | 1 | 2023 | 2646 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1260 | 0.020 |
Why?
| Cohort Studies | 1 | 2022 | 5378 | 0.020 |
Why?
| Nursing Homes | 1 | 1993 | 154 | 0.020 |
Why?
| Lung | 1 | 2004 | 3745 | 0.020 |
Why?
| Pain | 2 | 2009 | 748 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2011 | 55 | 0.020 |
Why?
| Pneumonia | 1 | 2016 | 600 | 0.020 |
Why?
| Child | 2 | 2020 | 20636 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 5034 | 0.020 |
Why?
| Equipment Safety | 1 | 2009 | 38 | 0.020 |
Why?
| Anti-Bacterial Agents | 1 | 1999 | 1689 | 0.020 |
Why?
| Ligation | 1 | 2008 | 86 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 1114 | 0.020 |
Why?
| Illinois | 1 | 2008 | 39 | 0.020 |
Why?
| Tissue and Organ Harvesting | 1 | 2008 | 72 | 0.020 |
Why?
| Smoking | 1 | 2015 | 1459 | 0.020 |
Why?
| Equipment Design | 1 | 2009 | 515 | 0.020 |
Why?
| Cardiovascular Agents | 1 | 2009 | 152 | 0.020 |
Why?
| Constriction, Pathologic | 1 | 2008 | 228 | 0.020 |
Why?
| Ulcer | 1 | 2007 | 29 | 0.020 |
Why?
| Magnetic Resonance Angiography | 1 | 2009 | 235 | 0.020 |
Why?
| Cerebral Arterial Diseases | 1 | 2007 | 44 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 709 | 0.020 |
Why?
| Drug Carriers | 1 | 2006 | 116 | 0.010 |
Why?
| Infusions, Intravenous | 1 | 2006 | 390 | 0.010 |
Why?
| Sterol O-Acyltransferase | 1 | 2004 | 5 | 0.010 |
Why?
| Acetamides | 1 | 2004 | 36 | 0.010 |
Why?
| Reference Values | 1 | 2006 | 776 | 0.010 |
Why?
| Cost-Benefit Analysis | 1 | 2007 | 567 | 0.010 |
Why?
| Hemodynamics | 1 | 2009 | 1077 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2006 | 755 | 0.010 |
Why?
| Hyperemia | 1 | 2004 | 46 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2004 | 404 | 0.010 |
Why?
| Ultrasonography | 1 | 2006 | 708 | 0.010 |
Why?
| Lipids | 1 | 2006 | 619 | 0.010 |
Why?
| Treatment Refusal | 1 | 2002 | 87 | 0.010 |
Why?
| Sulfonamides | 1 | 2004 | 494 | 0.010 |
Why?
| World Health Organization | 1 | 2000 | 110 | 0.010 |
Why?
| Costs and Cost Analysis | 1 | 2000 | 200 | 0.010 |
Why?
| Heart Function Tests | 1 | 2000 | 59 | 0.010 |
Why?
| Algorithms | 1 | 2007 | 1609 | 0.010 |
Why?
| Aneurysm, Ruptured | 1 | 1998 | 34 | 0.010 |
Why?
| Epoprostenol | 1 | 1999 | 134 | 0.010 |
Why?
| Models, Theoretical | 1 | 2000 | 541 | 0.010 |
Why?
| Gangrene | 1 | 1996 | 10 | 0.010 |
Why?
| Patient Satisfaction | 1 | 2000 | 624 | 0.010 |
Why?
| Embolization, Therapeutic | 1 | 1998 | 205 | 0.010 |
Why?
| Ultrasonography, Doppler, Color | 1 | 1995 | 37 | 0.010 |
Why?
| Health Status | 1 | 2000 | 747 | 0.010 |
Why?
| Behcet Syndrome | 1 | 1993 | 18 | 0.010 |
Why?
| Takayasu Arteritis | 1 | 1993 | 15 | 0.010 |
Why?
| Infant, Newborn | 1 | 1999 | 5688 | 0.000 |
Why?
|
|
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|